Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New state-level study locations were added (California, Massachusetts, Texas), and the page revision was updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T21:40:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Publications section now notes that entries are auto-filled from PubMed and may not pertain to the study, and the page revision is updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:56:44.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The funding-lapse disclaimer at the bottom of the page has been removed; this is a non-critical change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:10:11.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Publications related to the study were added and core trial details such as start date, completion date, enrollment, and locations were updated.
    Difference
    0.4%
    Check dated 2025-11-03T21:00:24.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:23:01.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:02:38.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.